| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|---|
| Net loss | -197 | -611 | -2,387 | -11,212 |
| Depreciation | 1 | 4 | 1 | 6 |
| Gain on deconsolidation of subsidiary | NaN | 0 | 4,947 | NaN |
| Prepaid expenses and other assets | NaN | -2,232 | -1,855 | NaN |
| Stock-based compensation | 1 | 655 | 1,679 | 592 |
| Changes in lease liability | -2 | -3 | 5 | -37 |
| Accounts receivable, net | -69 | 532 | 725 | NaN |
| Inventory | -437 | 16 | 1,368 | NaN |
| Prepaid expenses and other assets | 52 | NaN | NaN | -4,472 |
| Accounts payable, accrued and other current liabilities | -535 | -1,762 | -8,744 | -1,811 |
| Net cash used in operating activities | -278 | -33 | -4,737 | -7,990 |
| Purchase of property, plant and equipment | 1 | NaN | NaN | NaN |
| Net cash used in investing activities | -1 | NaN | NaN | NaN |
| Proceeds, net of issuance costs, from issuing common stock and pre-funded warrants, net | 125 | 861 | 5,564 | 6,209 |
| Payment made under the warrant exchange amendment | NaN | 1,100 | NaN | NaN |
| Proceeds from the exercise of stock options and warrants, net of issuance costs | NaN | NaN | NaN | 1,613 |
| Payment of preferred stock dividend | 20 | 20 | 41 | NaN |
| Net cash provided by financing activities | 105 | -259 | 5,523 | 7,822 |
| Effect of exchange rate changes on cash and cash equivalents | 8 | -41 | -85 | -73 |
| Net (decrease) increase in cash and cash equivalents | -166 | -333 | 701 | -241 |
| Cash and cash equivalents, beginning of period | 3,505 | 3,838 | 3,137 | 3,378 |
| Cash and cash equivalents, end of period | 3,339 | 3,505 | 3,838 | 3,137 |
Bio Green Med Solution, Inc. (BGMSP)
Bio Green Med Solution, Inc. (BGMSP)